Benin Management Corp’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-298
Closed -$7K 97
2019
Q1
$7K Hold
298
﹤0.01% 93
2018
Q4
$13K Hold
298
0.01% 90
2018
Q3
$25K Hold
298
0.01% 96
2018
Q2
$20K Hold
298
0.01% 94
2018
Q1
$22K Hold
298
0.01% 92
2017
Q4
$29K Hold
298
0.01% 94
2017
Q3
$35K Buy
+298
New +$32.1K 0.01% 96
2017
Q2
Sell
-256
Closed -$63K 100
2017
Q1
$63K Buy
256
+21
+9% +$2.72K 0.03% 99
2016
Q4
$16K Buy
235
+41
+21% +$3.34K 0.01% 101
2016
Q3
$20K Buy
194
+21
+12% +$2.54K 0.01% 102
2016
Q2
$21K Hold
173
0.01% 98
2016
Q1
$27K Hold
173
0.01% 96
2015
Q4
$30K Hold
173
0.02% 95
2015
Q3
$43K Hold
173
0.02% 98
2015
Q2
$50K Hold
173
0.03% 97
2015
Q1
$61K Hold
173
0.03% 98
2014
Q4
$58K Hold
173
0.03% 94
2014
Q3
$67K Hold
173
0.03% 101
2014
Q2
$72K Hold
173
0.04% 96
2014
Q1
$90K Hold
173
0.06% 93
2013
Q4
$42K Hold
173
0.03% 96
2013
Q3
$38K Hold
173
0.02% 93
2013
Q2
$37K Buy
+173
New +$29.7K 0.02% 96

Other funds holding IRD

Benin Management Corp's IRD Position: Q2 2019 in Review

Benin Management Corp sold out of Opus Genetics (IRD) in Q2 2019, closing a stake of 298 shares — an estimated $7K sold.

Benin Management Corp first reported a position in IRD in Q2 2013 and held it in 23 quarters. The position peaked at $90K in Q1 2014. 16 funds tracked by Wall St. Rank hold IRD as of Q2 2019.

  • Benin Management Corp reported no remaining Opus Genetics position as of Q2 2019 after selling out during the quarter.
  • Benin Management Corp sold 298 Opus Genetics shares in Q2 2019, an estimated $7K.
  • Benin Management Corp first reported a position in Opus Genetics in Q2 2013 and held it in 23 quarters.
  • Benin Management Corp's Opus Genetics position peaked at $90K in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2019.

Based on Benin Management Corp's 13F filing for Q2 2019, filed 31 Jul 2019.